PurpleStride Washington D.C. Aims to Change the Course of Nation’s Toughest Cancer

Funds raised at PurpleStride, the walk to end pancreatic cancer, support vital research and clinical initiatives of the Pancreatic Cancer Action Network

American singer/songwriter most notably known for her appearance as a semi-finalist on NBC’s television show “The Voice.” She was also one of two final contestants on Blake Shelton’s team during season 2. Following the show, she released her self-titled debut EP. Erin continues to give back to the community often partnering with the Pancreatic Cancer Action Network to fight the disease that took her father’s life in 2011. (Graphic: Business Wire)

???pagination.previous??? ???pagination.next???

WASHINGTON--()--The Pancreatic Cancer Action Network’s National Capital Area Affiliate invites the community to walk to end pancreatic cancer at PurpleStride Washington D.C., presented by the Washington Capitals, on Saturday, June 10, at Freedom Plaza.

In addition to thousands of local supporters, patients and survivors, PurpleStride Washington D.C. will welcome “The Voice” season two semi-finalist Erin Willett, who will perform the National Anthem.

Pancreatic cancer is the nation’s deadliest major cancer, with a five-year survival of just 9 percent. The Pancreatic Cancer Action Network (PanCAN) is a trailblazing organization addressing pancreatic cancer through research, clinical initiatives, patient services and advocacy with an immediate mission to improve patient outcomes today and to double pancreatic cancer survival by 2020.

“More than 53,000 Americans will be diagnosed with pancreatic cancer this year and 91 percent of those patients will not live past five years,” said Lynn Matrisian, PhD, MBA, chief science officer for the Pancreatic Cancer Action Network. “Funds raised through PurpleStride help advance pancreatic cancer research and ultimately improve patient outcomes.”

Each year, more than 80,000 people in cities across the U.S. Wage Hope at PurpleStride, the walk to end pancreatic cancer, and have raised more than $76 million since 2008. These funds support the organization’s key initiatives, including Precision Promise℠, Know Your Tumor® and the Patient Registry.

Josh Yazman, spokesperson for the National Capital Area Affiliate, lost his mother to pancreatic cancer in 2014 after a four-year battle with the disease.

“I knew about PanCAN since my mother’s diagnosis, but I didn’t get involved until a friend invited me to PurpleStride in 2014,” Yazman said. “After that first event, I was hooked on the commitment that everyone shared to improve patient outcomes. PurpleStride is an opportunity to connect with thousands of people affected by pancreatic cancer and take actionable steps towards finding a cure by fundraising.”

The Washington D.C. event is supported by national presenting sponsor Celgene; presenting sponsor Washington Capitals; national gold sponsor AbbVie; and gold sponsor Kovler Fund of CFNCR.

To register, donate or learn more about PurpleStride Washington D.C., please visit purplestride.org/dc. For more on PurpleStride and the Pancreatic Cancer Action Network, watch the PurpleStride PSA and the organization’s PSA.

About the Pancreatic Cancer Action Network

The Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world’s toughest cancer. In our urgent mission to save lives, we attack pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Our effort is amplified by a nationwide network of grassroots support. We are determined to improve patient outcomes today and to double survivor by 2020.

Contacts

Pancreatic Cancer Action Network
Kylee Burkholder, 310-706-3516
kburkholder@pancan.org

Release Summary

PurpleStride Washington D.C. Aims to Change the Course of Nation's Toughest Cancer

Contacts

Pancreatic Cancer Action Network
Kylee Burkholder, 310-706-3516
kburkholder@pancan.org